Retroperitoneal Liposarcoma

• CLINICAL_TRIALS trial_result · 2026-04-08
  Clinical Trial Update: Eribulin and Radiation Therapy in Treating Patients With Retroperitoneal Liposarcoma That Can Be Removed by Surgery [Phase 1]

  Phase 1 clinical trial update assessing eribulin in combination with radiation therapy for patients with surgically resectable retroperitone…

• CLINICAL_TRIALS research · 2026-01-30
  Clinical Trial Update: Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma

  This clinical trial update describes a prospective study evaluating treatment outcomes for localized recurrent, resectable retroperitoneal l…

• CLINICAL_TRIALS research · 2024-05-31
  Clinical Trial Update: Genomic Risk in Retroperitoneal Sarcoma

  A clinical trial update announcing ongoing recruitment for a study investigating genomic risk in retroperitoneal sarcoma, sponsored by Fox C…

• CLINICAL_TRIALS research · 2015-10-27
  Clinical Trial Update: Trial of Nilotinib and Adriamycin as Treatment in Liposarcomas and Leiomyosarcomas of Retroperitoneum [Phase 1, Phase 2]

  Clinical trial update on a Phase 1/2 study of nilotinib in combination with Adriamycin for retroperitoneal liposarcoma and retroperitoneal l…